MDT — Medtronic plc
$102.86
+$1.87 (+1.85%)
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio.
Market Cap
$131.57B
Forward P/E
16.1x
52-Week Range
N/A
MDT Price History
Revenue vs. Net Income
$36.3B
Revenue · FY2026
Annual. Net margin is shown under each year.
Free Cash Flow
$5.4B
FCF · FY2026
Annual. FCF margin is shown under each year.
Return on Capital Employed (ROCE)
8.4%
ROCE · FY2026
Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.
Total Assets vs. Total Liabilities
2.1x
Assets ÷ liabilities · FY2026
Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.
CapEx as % of Revenue
5.2%
CapEx · FY2026
Annual. Green at or under the 5% maximum target, red above it.
Shares Outstanding
-0.1%
Net buyback · FY2026
Annual diluted shares. Under each year: the change on the previous year (green = buyback, amber = dilution).
